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| INTRODUC TI ON
α-Thalassemia is prevalent in the southern regions of China, and especially in Guangxi Zhuang Autonomous Region where the carrier rate of population is up to 17.55%. 1 The more serious types of α-thalassemia are Hb H disease and Hb Bart's hydrops fetalis which cause moderate or severe anemia or fetal abortion. The main genotype that causes Hb H disease is α 0 /α + , 2 but Hb Bart's hydrops fetalis is α 0 /α 0 . 3 Hb H disease is caused by deletion of both the HBA1 (α1) and HBA2 (α2) genes on one chromosome 16 and either a complete deletion or a point mutation on HBA1 or HBA2 on the other homologue. 4 In the southern Chinese population, the main of the twogene deletion in cis is --SEA (α 0 ) and --Thai (α 0 ). Single-gene deletions -α 3.7 (α + ) or -α 4.2 (α + ) are majority of deletional Hb H disease, while Hb Constant Spring (Hb CS) (α + ) or Hb Quong Sze (Hb QS) (α + ) predominates in the non-deletional form. In addition, there are a few rare mutations reported in Chinese patients with α-thalassemia. [4] [5] [6] [7] Here, we describe a novel mutation CD 90-93 (-AGCTTCGG) in the α2 gene combined deletion --SEA causing Hb H disease in a Chinese patient.
| MATERIAL S AND ME THODS

| Patients and clinical presentation
The proband was a 2-year-old boy who came from Baise City, Guangxi Zhuang Autonomous Region of southern China. There was no obvious retardation of growth during pregnancy and no history of jaundice at birth. He was recommended to our hospital for further diagnosis because of the clinical phenotype of moderate anemia diagnosed in a local hospital. Blood samples of him and his parents were collected using EDTA as anticoagulant after informed consent was obtained. 
| Hematological analysis
| Routine genetic analysis
Genomic DNA was extracted from peripheral blood using thalassemia detection kit (Yishengtang). Identification of common αthalassemia in China including α-thalassemia 1 (--SEA and --Thai deletions) and α-thalassemia 2 (-α 3.7 and -α 4.2 deletions) was performed routinely in our laboratory using the gap-PCR method 
| DNA sequencing
Two sets of primer pairs were designated and used to amplify and sequence the α-globin gene (α1and α2) as shown in Table 1 
TA B L E 2 Hematological data and globin genotype of patients
| RE SULTS
| Hematological characteristics and Hb analysis
Hematological characteristics and Hb analysis of three samples are summarized in Table 2 . As shown in Table 2 , there was a decrease in Hb (87 g/L, normal reference range 120-160 g/L) of the proband obviously. In addition, Hb analysis using capillary electrophoresis system showed Hb H peak, Hb Bart's peak, and decreased Hb A2 
| Routine genetic analysis and DNA sequencing
The multiplex gap-PCR for the most common deletions gave a result of --SEA /heterozygote deletion, suggesting a discrepancy between genotype and phenotype, and a second mutation/deletion was considered ( Figure 2 ). No mutations of three common non-deletions of α-thalassemia and common β-thalassemia were detected by PCR-RDB. The data of α-globin gene DNA sequencing revealed that a novel mutation was identified at codon 90-93 (-AGCTTCGG) on the α2 gene, and the breakpoints were located between nts 34162 and 34171 ( Figure 3 ).
| CON CLUS ION
Now, in laboratories of Chinese hospitals, the genotypes of usually used α-thalassemia genetic analysis kits were deletion genotype including --SEA , --Thai , -α 3.7 , and -α 4.2 , and non-deletion containing α CS α, α WS α, and α QS α. They are the major α-thalassemia genotypes in the Chinese population, but not all the genotypes. 8 In other words, patients with novel genotypes may be missed diagnosis using routine genetic analysis kits. It is important for identification and clinical genetics analysis of novel mutation in the prevalent region.
Here, we report for the first time, in Chinese patient, a novel (Figure 1 ). It was a typical picture of Hb H disease. Subsequently, he was advised to . Lanes 1-3 were the proband, mother, and fetus. All genotypes of them were found heterozygous of deletion -SEA (--SEA / αα). Lane 4 was the father, and the genotypes were -α CD90-93 /α CD90-93 , but the result of electrophoresis showed the same as normal sample.
continue genetic analysis. However, only heterozygote deletion --SEA s was detected after 3 days ( Figure 2 ). According to our experiences, it suggested that there was a rare or novel mutation.
Thus, his mother and father were also recommended to the same detection. Finally, DNA sequencing showed that the novel mutation was a mutation at codon 90-93 (-AGCTTCGG) on the α2 gene. It was obtained the registration number (KJ400031) of National Center for Biotechnology Information (NCBI) GenBank. The father was a homogenous codon 90-93 (-AGCTTCGG) (genotyped:-α CD90-93 /-α CD90-93 ), and the proband was codon 90-93 (-AGCTTCGG) combining deletion --SEA (genotyped: --SEA /-α CD90-93 ). As the phenotype of homogenous codon 90-93 (-AGCTTCGG) is similar to heterozygous of deletion --SEA , we presumed that the individual heterozygous of codon 90-93 (-AGCTTCGG) (α + ) may be generally normal and similar to heterozygous of -α 3.7 . Surprisingly, fetus, a second baby, was detected by the same genotype as the proband by amniocentesis after a year.
In this study, firstly, we noticed that there was a Hb H disease from the result of CE, and the genetic analysis data in turn confirmed.
Almost all of the Hb H disease can be separated out of the H band, so the result of CE may be used as a proof for Hb H disease whether it is caused by the well-known genotypes or the novel mutation genotypes. Relative to the low specificity of anemia in hematological analysis, CE is a good method for Hb H disease detection. As in this case, it was likely to cause misdiagnosis if there was no result of CE. 
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